Samuel W. Chung, M.D.

626-218-9840
Samuel W. Chung, M.D.
Medical Oncologist and Hematologist
Clinical Expertise
  • Lung Cancer
  • Gastrointestinal Cancers
  • Hematology
  • Genitourinary Cancers
Other Languages Spoken
Cantonese
Academic Appointments
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
Clinical Teams
Thoracic Oncology
Medical Oncology & Therapeutics Research

Samuel W. Chung, M.D., a medical oncologist, earned his undergraduate degree in biology from the University of California at Riverside and his medical degree from the Loma Linda University School of Medicine. In 2003, he began his residency in internal medicine at the Roger Williams Medical Center at Boston University where he was chosen as chief resident in 2006. He went on to complete a fellowship in hematology/oncology with the UCLA-Olive View Program in Sylmar, California.

Dr. Chung came to City of Hope® in 2012. Prior to joining the City of Hope team, he worked with the Wilshire Oncology Medical Group in Pasadena. He is board certified in hematology, medical oncology and internal medicine, and is a member of numerous professional societies.

Location

Education & Experience

Board Certifications

  • 2010, American Board of Internal Medicine, Medical Oncology
  • 2010, American Board of Internal Medicine, Hematology

Degrees

  • 1999–2003 Loma Linda University School of Medicine, Loma Linda, CA, M.D.
  • 1995–1999 University of California, Riverside, Riverside, CA, Biology, B.S.

Fellowship

  • 2007–2010 UCLA-Olive View Program/Cedars Sinai Medical Center, Sylmar, CA, Hematology/Oncology, Fellow

Residency

  • 2006–2007 Roger Williams Medical Center, Boston University, Providence, RI, Chief Medical Resident
  • 2003–2006 Roger Williams Medical Center, Boston University, Providence, RI, Medical Resident

Professional Experience

  • 2022–Present, Staff Physician, Department of Medicine Glendale, Memorial Hospital, Glendale, California
  • 2022–Present, Staff Physician, Department of Medicine, Verdugo Hills Hospital, Glendale, California
  • 2022–Present, Staff Physician, Department of Medicine, Glendale Adventist Hospital, Glendale, California
  • 2012–Present, Assistant Clinical Professor, Department of Oncology & Therapeutics Research, City of Hope — South Pasadena and Arcadia, California
  • 2012–Present, Staff Physician, Department of Medicine, Methodist Hospital of Southern California, Arcadia, California
  • 2011–Present, Staff Physician, Department of Medicine, Section of Hematology/Oncology, Huntington Hospital, Pasadena, California
  • 2011–2015, Staff Physician, Department of Medicine, Verdugo Hospital, Glendale, California

Awards & Memberships

Awards

  • 2017, Pasadena Magazine, Top Doctors
  • 2013, Pasadena Magazine, Top Doctors
  • 2010, American Medical Association (AMA), Physician Recognition Award
  • 2005, Associate's Forum Winner, Rhode Island Chapter, American College of Physicians, Warwick, RI

Memberships

  • 2011, Southwest Oncology Group
  • 2010, American Society of Clinical Oncology
  • 2010, American Society of Hematology

Publications

  • Ge X, Yost SE, Lee JS, Frankel PH, Ruel C, Cui Y, Murga M, Tang A, Martinez N, Chung S, Yeon C, Stewart D, Li D, Rajurkar S, Somlo G, Mortimer J, Waisman J, Yuan Y. Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer. Cancers (Basel). 2022 Sep 1;14(17):4279.
  • Pharaon R., Chung S., Amini A., Maghami E., Chowdhury A., Vora N., Chang S., Kang R., Gernon T., Hansen K., Kelly C., Ackerman D., Vora L., Sampath S., Massarelli E. An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center sites. Journal of Clinical Medicine. 2020, 9(10), 3083.
  • Mortimer J., Kruper L., Jung J., Wong L., Cooper J., Stewart D., Chung S., Yu K.W., Dadwal, S., Yuan Y. Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab. Cancer Chemotherapy and Pharmacology. 85, 501-507 (2020).
  • Mortimer J., Jung J., Yuan Y., Kruper L., Stewart D., Chung S., Wai Yu K., Mendelsohn M., D’Apuzzo M., Tegtmeier B., Dadwal S. Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy. Breast Cancer Research and Treatment. 2014 Dec;148(3):563-570.
  • Colvin G., Berz D., Liu L., Dooner M., Dooner G., Pascual S., Chung S., Sui Y., Quesenberry P. Heterogeneity of Non-cycling and Cycling Synchronized Murine Hematopoietic Stem/Progenitor Cells. Journal of Cellular Physiology. 2010 Jan;222(1):57-65
  • Colvin, GA., Dooner, MS., Dooner, GJ., Sanchez-Guijo, FM., Demers, DA., Abedi, M., Ramanathan, M., Chung, S., Pascual, S., Quesenberry, PJ. Stem cell continuum: Directed differentiation hotspots. Experimental Hematology. 2007 Jan; 35:96-107.

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
5.0
Show respect for what you say
4.9
Recommend this provider office
4.9
Provider explain in way you understand
4.9
Provider listen carefully to you
4.9
Spend enough time with you
4.8
Know important info medical history
4.8
Rate provider 0-10
03/27/26
ALWAYS! Very good experience. - Verified patient
03/27/26
LOVE CITY OF HOPE and this Arcadia office!! - Verified patient
03/25/26
I am fortunate seeing Dr. Samuel Chung.Aside from saving my life, he has an unquantifiable talent for good.It's beyond skill. Dr. Samuel Chung.is extraordinary medicine. - Verified patient
03/18/26
Staff was wondeful - Verified patient
03/18/26
Samuel was great. Happy to see him - Verified patient